MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-HR-13-0003043
Suntril Pharmaceuticals Private Limited - pharma in Chandigarh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹5.45 Cr
▲ 19% YoY
Net profit · FY 2024
₹2.96 Lakh
Net margin 0.5%
EBITDA · FY 2024
₹67.36 Lakh
EBITDA margin 12.4%
Authorised capital
₹2.2 Cr
Registered with MCA
Paid-up capital
₹2.2 Cr
Issued & subscribed
Open charges
₹4.52 Cr
Secured borrowings
Company age
13 yrs
Est. 2013
Employees · EPFO
18
Provident fund records
About Suntril Pharmaceuticals Private Limited
Data last updated:
Suntril Pharmaceuticals Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 November 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH2013PTC034849. Its GSTIN is 06AATCS9654G1ZN (Haryana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹2.2 Cr and a paid-up capital of ₹2.2 Cr. It is led by directors Pardeep Narula (Managing Director) and Trilok Chand Narula.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H No. 124/1 Sector 45 A, Chandigarh, India – 160045.
As per the financials filed for FY 2024, the company reported a revenue of ₹5.45 Cr, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹2.96 Lakh (net margin 0.5%) and EBITDA of ₹67.36 Lakh (EBITDA margin 12.4%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 22% over five years.
The company has about 18 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹4.52 Cr on record.
Suntril Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-13-0003043). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website suntrilpharma.com.
Company details
CIN U24232CH2013PTC034849
Registration Number 034849
Incorporation Date 29 November 2013
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-HR-13-0003043
Recognitions & Rankings of Suntril Pharmaceuticals
Contact details
Suntril Pharmaceuticals Private Limited's registered office is in Chandigarh, Chandigarh. Its website is suntrilpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressH No. 124/1 Sector 45 A, Chandigarh, India – 160045
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Suntril Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Suntril Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Suntril Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Suntril Pharmaceuticals Private Limited, buy the company report.
Financials of Suntril Pharmaceuticals Private Limited
FY 2024 filings availableSuntril Pharmaceuticals Private Limited reported revenue of ₹5.45 Cr (up 19% YoY) for FY 2024.
Revenue · FY 2024
₹5.45 Cr ▲ 19%
Net profit · FY 2024
₹2.96 Lakh margin 0.5%
EBITDA · FY 2024
₹67.36 Lakh margin 12.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 19%
3 years · compounded
▲ 5%
5 years · compounded
▲ 22%
EBITDA CAGR growth
1 year
▲ 49%
3 years · compounded
▼ 17%
5 years · compounded
▲ 25%
Revenue has grown at a compounded annual rate (CAGR) of 22% over five years, including 19% growth in the latest year. EBITDA rose 49% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹67.36 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.96 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.4% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Suntril Pharmaceuticals Private Limited, buy the company report.
Board of directors of Suntril Pharmaceuticals Private Limited
Suntril Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Trilok Chand Narula | Additional Director | 13 Apr 2015 | 11 Years 6 Months | Current |
| Pardeep Narula | Managing Director | 29 Nov 2013 | 12 Years 10 Months | Current |
Peer comparison
Suntril Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Arient Scientific Private Limited | ₹5.46 Cr (FY 2016) | 35.0% | Thane, Maharashtra, India | |||
| A B S Remedies Private Limited | ₹5.45 Cr (FY 2025) | -2.0% | New Delhi, Delhi, India | |||
| Suntril Pharmaceuticals Private Limitedthis company | ₹5.45 Cr (FY 2024) | ₹2.96 Lakh | 0.5% | 19.0% | 18 | Chandigarh, India |
| Aripolis Biotech Private Limited | ₹5.45 Cr (FY 2025) | 10.0% | Ludhiana, Punjab, India | |||
| Rako Agrochem Private Limited | ₹5.43 Cr (FY 2025) | 9.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Suntril Pharmaceuticals Private Limited, buy the company report.
Auditor
Suntril Pharmaceuticals Private Limited is audited by B V R & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B V R & CO | FY 2022 | 005558N |
Shareholding
The shareholding of Suntril Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Suntril Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹4.52 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Nov 2021 | 100513484 | Bank of India | ₹37.69 Lakh | Open | |
| 15 Sep 2015 | 10597325 | Bank of India | ₹4.14 Cr | Open |
To see the full charge records of Suntril Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Suntril Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Suntril Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Suntril Pharmaceuticals Private Limited has a workforce of 18 employees on its EPFO records as of Apr 02, 2024, across 1 active EPFO establishment.
Employee count
18
Active EPFO establishments
1
Employee growth
5.88%
GST
Suntril Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AATCS9654G1ZN | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Suntril Pharmaceuticals Private Limited, buy the company report.
Recent activity
Suntril Pharmaceuticals Private Limited has 3 board changes on record since 2013: 2 appointments and 1 cessation. The latest: Leena Rana ceased to be Director on 13 Apr 2015.
AGM
Suntril Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Suntril Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh.
Charges
A charge with Bank Of India amounted to Rs. 0.38 Cr with Charge ID 100513484 was registered on 25 Nov 2021.
Charges
A charge with Bank Of India of Rs. 4.14 Cr registered on 15 Sep 2015 with Charge ID 10597325 was modified on 14 Aug 2020.
Charges
A charge with Bank Of India amounted to Rs. 4.14 Cr with Charge ID 10597325 was registered on 15 Sep 2015.
Ceased
Leena Rana ceased to be Director.
Appointed
Trilok Chand Narula was appointed as Additional Director.
Appointed
Pardeep Narula was appointed as Managing Director.
Incorporation
29 Nov 2013
Suntril Pharmaceuticals Private Limited was registered on 29 Nov 2013 with Roc Chandigarh & aged 12 years 10 months as per MCA records.
Frequently asked questions
Suntril Pharmaceuticals is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 November 2013 (13+ years old) and is registered under CIN U24232CH2013PTC034849.
Suntril Pharmaceuticals has 2 current directors:
- Pardeep Narula - Managing Director
- Trilok Chand Narula - Additional Director
The latest financial statements of Suntril Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Suntril Pharmaceuticals is 06AATCS9654G1ZN, registered in Haryana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Suntril Pharmaceuticals is U24232CH2013PTC034849. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Suntril Pharmaceuticals was incorporated on 29 November 2013, making it 13+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Suntril Pharmaceuticals by revenue are Arient Scientific Private Limited, A B S Remedies Private Limited, Aripolis Biotech Private Limited, Rako Agrochem Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Leena Rana ceased to be Director on 13 Apr 2015. Trilok Chand Narula was appointed as Additional Director on 13 Apr 2015. Pardeep Narula was appointed as Managing Director on 29 Nov 2013.
Yes, Suntril Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-13-0003043).
Suntril Pharmaceuticals can be reached through the website suntrilpharma.com. Its registered office is in Chandigarh, India.
The registered office of Suntril Pharmaceuticals is at H No. 1241 Sector 45 A, Chandigarh, India – 160045.